Skip to main content
18 Jan | 2022

The "la Caixa" Foundation awards a postdoctoral fellowship to Dr. Marc Suárez-Calvet

Within the framework of the INPhINIT doctoral scholarship program, 65 scholarships have been awarded, and 45 excellent researchers have been awarded in the Junior Leader postdoctoral program.

22 Nov | 2021

We detect that music related to life experiences activates parts of the brain other than those involved in the natural process of remembering.

A work led at the Barcelonaβeta Brain Research Center (BBRC), our research center, has studied the relationship between music and autobiographical memories.

18 Nov | 2021

Betascreen is born, the first spin-off of the Pasqual Maragall Foundation for the detection of Alzheimer's in the preclinical phase

A technology company promoted by the Barcelonaβeta Brain Research Center (BBRC) in conjunction with the researchers Dr. Juan Domingo Gispert and Dr. José Luis Molinuevo.

17 Nov | 2021

The Barcelonaβeta Brain Research Center launches a laboratory for the early detection of Alzheimer's with a blood test

Dr. Marc Suárez-Calvet, head of the Biomarkers in Fluids and Traslational Neurology group, will lead the new center aimed at developing, validating and applying new biomarkers for Alzheimer's disease.

19 Oct | 2021

Identified in the blood a biomarker that allows to detect in a very precise way the initial phases of the Alzheimer’s disease

Researchers at the Pasqual Maragall Foundation's research center, the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation, have detected that the glial fibrillar acid protein (GFAP) is a very accurate biomarker for diagnosing in blood the early stages of Alzheimer’s disease. 

08 Oct | 2021

BBRC researchers collaborate in a study from the Hospital del Mar that changes the approach to preventive treatment of brain metastasis in lung cancer

The research team in Neuroimage, guided by Dr. Juan Domingo Gispert, has participated in the study.

23 Jul | 2021

The project on artificial intelligence algorithms in magnetic resonance obtains a 'Digital EIT 2021'

The organization under the European Commission will finance part of the project

15 Jul | 2021

"A titanic effort is being made to understand Alzheimer's disease in its early stages"

Interview with Gemma Salvadó, researcher of the Neuroimaging Group, after obtaining her PhD

13 Jul | 2021

Identified a new association between light neurofilaments and other markers of Alzheimer's disease

Researchers at the Barcelonaβeta Brain Research Center (BBRC) have identified that people with amyloid pathology and subjective cognitive impairment have an increase in light neurofilaments (NfL) in the cerebrospinal fluid and a lower volume in the hippocampus.